PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 84 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 4.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,548,000 | -7.2% | 670,371 | +24.3% | 0.00% | 0.0% |
| Q4 2019 | $2,747,000 | +41.4% | 539,506 | +40.3% | 0.00% | 0.0% |
| Q3 2019 | $1,943,000 | -35.4% | 384,435 | -21.2% | 0.00% | 0.0% |
| Q2 2019 | $3,009,000 | +22.2% | 487,736 | -8.1% | 0.00% | 0.0% |
| Q1 2019 | $2,463,000 | +45.0% | 530,782 | +31.2% | 0.00% | 0.0% |
| Q4 2018 | $1,699,000 | -46.2% | 404,573 | -19.6% | 0.00% | 0.0% |
| Q3 2018 | $3,156,000 | -58.1% | 503,349 | -46.2% | 0.00% | -50.0% |
| Q2 2018 | $7,524,000 | +225.4% | 935,821 | +202.1% | 0.00% | +100.0% |
| Q1 2018 | $2,312,000 | +63.0% | 309,778 | +30.0% | 0.00% | – |
| Q4 2017 | $1,418,000 | +1.9% | 238,358 | +26.0% | 0.00% | – |
| Q3 2017 | $1,392,000 | +73.1% | 189,143 | +59.7% | 0.00% | – |
| Q2 2017 | $804,000 | -84.5% | 118,459 | -78.4% | 0.00% | -100.0% |
| Q1 2017 | $5,172,000 | -20.6% | 548,130 | -27.3% | 0.00% | 0.0% |
| Q4 2016 | $6,512,000 | +1421.5% | 753,772 | +1016.1% | 0.00% | – |
| Q3 2016 | $428,000 | +328.0% | 67,536 | +185.5% | 0.00% | – |
| Q2 2016 | $100,000 | +20.5% | 23,652 | +23.9% | 0.00% | – |
| Q1 2016 | $83,000 | -17.8% | 19,089 | +15.5% | 0.00% | – |
| Q4 2015 | $101,000 | +11.0% | 16,530 | +3.8% | 0.00% | – |
| Q3 2015 | $91,000 | -80.8% | 15,921 | -74.9% | 0.00% | – |
| Q2 2015 | $474,000 | -81.9% | 63,425 | -85.5% | 0.00% | -100.0% |
| Q1 2015 | $2,617,000 | -17.5% | 437,573 | +4.3% | 0.00% | 0.0% |
| Q4 2014 | $3,173,000 | -25.0% | 419,707 | -48.5% | 0.00% | -50.0% |
| Q3 2014 | $4,229,000 | +15.4% | 814,948 | -4.2% | 0.00% | +100.0% |
| Q2 2014 | $3,666,000 | +17.6% | 850,404 | +11.5% | 0.00% | 0.0% |
| Q1 2014 | $3,118,000 | -19.0% | 762,426 | +5.6% | 0.00% | -50.0% |
| Q4 2013 | $3,850,000 | -32.5% | 722,245 | -36.4% | 0.00% | -33.3% |
| Q3 2013 | $5,700,000 | +24.0% | 1,135,598 | +10.2% | 0.00% | +50.0% |
| Q2 2013 | $4,596,000 | – | 1,030,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|